Lidocaine Patent Expiration
Lidocaine is Used for managing pain associated with post-herpetic neuralgia. It was first introduced by Astrazeneca Lp
Lidocaine Patents
Given below is the list of patents protecting Lidocaine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Lidoderm | US5741510 | Adhesive patch for applying analgesic medication to the skin |
Mar 30, 2014
(Expired) | Teikoku Pharma Usa |
Lidoderm | US5827529 | External preparation for application to the skin containing lidocaine |
Oct 27, 2015
(Expired) | Teikoku Pharma Usa |
Ztlido | US10765640 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US10765749 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US11278623 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US11786455 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US11793766 | Non-aqueous patch for the relief of pain | May 10, 2031 | Scilex Pharms |
Ztlido | US9283174 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US9925264 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
Ztlido | US9931403 | Non-aqueous patch | May 10, 2031 | Scilex Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lidocaine's patents.
Latest Legal Activities on Lidocaine's Patents
Given below is the list recent legal activities going on the following patents of Lidocaine.
Event | Date | Patent/Publication |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 4th Year, Large Entity | 21 Feb, 2024 | US10765640 |
Payment of Maintenance Fee, 4th Year, Large Entity | 21 Feb, 2024 | US10765749 |
Mail Patent eGrant Notification | 24 Oct, 2023 | US11793766 |
Patent eGrant Notification | 24 Oct, 2023 | US11793766 |
Recordation of Patent eGrant | 24 Oct, 2023 | US11793766 |
Recordation of Patent Grant Mailed | 24 Oct, 2023 | US11793766 |
Email Notification | 24 Oct, 2023 | US11793766 |
Patent Issue Date Used in PTA Calculation | 24 Oct, 2023 | US11793766 |
Patent eGrant Notification | 17 Oct, 2023 | US11786455 |
Email Notification | 17 Oct, 2023 | US11786455 |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Lidocaine Generics
Several generic applications have been filed for Lidocaine. The first generic version for Lidocaine was by Fougera Pharmaceuticals Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jun 18, 2024.
Given below is the list of companies who have filed for Lidocaine generic.
1. SEPTODONT INC
Septodont Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Septodont Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | May 23, 2011 |
2. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Taro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Approved Prior to Jan 1, 1982 |
3. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Prescription | TOPICAL | AB | Aug 24, 2020 |
4. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Dec 11, 2018 |
5. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Cosette.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Dec 12, 2018 |
6. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Aug 7, 2015 |
7. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Nov 23, 2018 |
8. QUAGEN
Quagen Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Quagen.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Apr 20, 2021 |
9. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Encube.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Feb 1, 2016 |
10. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Jan 16, 2018 |
11. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%
(reference standard) (reference listed drug) | ointment | Prescription | TOPICAL | AT | Approved Prior to Jan 1, 1982 |
12. CARLISLE
Carlisle Laboratories Inc has filed for 1 generic for Lidocaine. This 5% version comes by the name ALPHACAINE. Given below are the details of the strengths of this generic introduced by Carlisle.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
13. IBSA
Ibsa Institut Biochimique Sa has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Ibsa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Prescription | TOPICAL | AB | Apr 30, 2020 |
14. ACTAVIS LABS UT INC
Actavis Laboratories Ut Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Prescription | TOPICAL | AB | Aug 23, 2012 |
15. BELMORA LLC
Belmora Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Belmora Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
16. AILEX PHARMS LLC
Ailex Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Ailex Pharms Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Oct 17, 2019 |
17. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Mar 16, 2020 |
18. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Sep 9, 2016 |
19. NAL PHARM
Nal Pharmaceutical Group Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Nal Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Prescription | TOPICAL | AB | Apr 29, 2021 |
20. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Jan 5, 2021 |
21. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Sep 20, 2017 |
22. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Jun 18, 2024 |
23. MYLAN TECHNOLOGIES
Mylan Technologies Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Mylan Technologies.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Prescription | TOPICAL | AB | Aug 7, 2015 |
24. VITRUVIAS THERAP
Vitruvias Therapeutics Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Vitruvias Therap.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Discontinued | TOPICAL | N/A | Sep 25, 2017 |
25. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | ointment | Prescription | TOPICAL | AT | Mar 10, 2017 |
26. NOVEN PHARMS INC
Noven Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Noven Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5% | patch | Discontinued | TOPICAL | N/A | Dec 1, 2020 |